Quick Answer
AIM ImmunoTech Inc. reported Total Revenue of $88.0 thousand for fiscal year 2025.
AIM ImmunoTech Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $88.0K | -48.2% |
| 2024 | $170.0K | -15.8% |
| 2023 | $202.0K | +43.3% |
| 2022 | $141.0K | +4.4% |
| 2021 | $135.0K | -17.2% |
| 2020 | $163.0K | +16.4% |
| 2019 | $140.0K | -61.9% |
| 2018 | $367.0K | -16.0% |
| 2017 | $437.0K | +375.0% |
| 2016 | $92.0K | -30.8% |
| 2015 | $133.0K | -32.5% |
| 2014 | $197.0K | +31.3% |
| 2013 | $150.0K | -29.6% |
| 2012 | $213.0K | +32.3% |
| 2011 | $161.0K | +19.3% |
| 2010 | $135.0K | +21.6% |
| 2009 | $111.0K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $26.0K | -25.7% | +4.0% |
| June 30, 2025 | $25.0K | -50.0% | +56.2% |
| March 31, 2025 | $16.0K | -60.0% | -54.3% |
| September 30, 2024 | $35.0K | -23.9% | -30.0% |
| June 30, 2024 | $50.0K | +19.0% | +25.0% |
| March 31, 2024 | $40.0K | -18.4% | -13.0% |
| September 30, 2023 | $46.0K | +119.0% | +9.5% |
| June 30, 2023 | $42.0K | +40.0% | -14.3% |
- AIM ImmunoTech Inc. showed a decrease of -48.2% in Total Revenue compared to the prior fiscal year.
- Over the 2009–2025 period, AIM ImmunoTech Inc.’s total revenue has declined by 20.7% (from $111.0 thousand to $88.0 thousand).
- The most recent figure is from AIM ImmunoTech Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: